Armstrong Advisory Group’s Biogen BIIB Stock Holding History

Armstrong Advisory Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$100K	Hold	443	–	–	0.01%	340
2026 Q2	$95.7K	Buy	+443	New	+$84.7K	0.01%	352
2026 Q1	–	Sell	-356	Closed	-$62.7K	–	967
2025 Q4	$62.7K	Hold	356	–	–	﹤0.01%	372
2025 Q3	$49.9K	Hold	356	–	–	﹤0.01%	397
2025 Q2	$44.7K	Hold	356	–	–	﹤0.01%	396
2025 Q1	$54.4K	Hold	356	–	–	﹤0.01%	365
2024 Q4	$54.4K	Hold	356	–	–	﹤0.01%	365
2024 Q3	$69K	Hold	356	–	–	0.01%	324
2024 Q2	$82.5K	Hold	356	–	–	0.01%	292
2024 Q1	$92.1K	Hold	356	–	–	0.01%	265
2023 Q4	$92.1K	Hold	356	–	–	0.01%	265
2023 Q3	$91.5K	Hold	356	–	–	0.01%	251
2023 Q2	$101K	Hold	356	–	–	0.01%	234
2023 Q1	$99K	Hold	356	–	–	0.01%	239
2022 Q4	$98.6K	Buy	+356	New	+$101K	0.01%	239

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Adams Diversified Equity Fund Baltimore, Maryland $3.3B AUM 38.12% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

Armstrong Advisory Group's BIIB Position: Q3 2026 in Review

Armstrong Advisory Group held its Biogen (BIIB) position steady in Q3 2026 at 443 shares worth $100K. The position accounts for 0.01% of the portfolio, ranked #340.

Armstrong Advisory Group first reported a position in BIIB in Q4 2022 and has held it in 15 quarters since. The position peaked at $101K in Q2 2023. 232 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

Armstrong Advisory Group held 443 shares of Biogen worth $100K as of Q3 2026.
Armstrong Advisory Group left its Biogen share count unchanged in Q3 2026.
Biogen made up 0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #340 holding.
Armstrong Advisory Group first reported a position in Biogen in Q4 2022 and has held it in 15 quarters since.
Armstrong Advisory Group's Biogen position peaked at $101K in Q2 2023.
232 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.